Copyright © 2019. Inderes Oy. All rights reserved.
Search
User account

Hei!

Luo ilmainen tili jotta voit seurata yrityksiä, osallistua foorumin keskusteluun sekä kommentoida meidän sisältöä. Valitse sinulle sopivin tili.

Oliko sinulla jo tili?

Log in
BBS-Bioactive Bone Substitutes
1639 investors follow this company
The company is not covered. See all listed companies from here.
BUY 6.40 LOWEST 6.30 VOLUME 2 292
SELL 6.50 HIGHEST 6.90 VALUE 0,015 Milj. EUR

Would you like to see our recommendations and target prices?

You already have an Inderes account? Log in from here.

Latest insider trading

Type: stock_exchange_release
27.3.
2020

BBS-Bioactive Bone Substitutes Plc has received a working capital loan to secure its financing

Company release 27.3.2020 at 17:00

Type: stock_exchange_release
20.3.
2020

Company Release 20.3.2020 at 9:00


BBS- Bioactive Bone Substitutes Plc's Financial Statements Review 1.1.-31.12.2019 (unaudited)


Year 2019 in brief (Reference period 2018)

Type: stock_exchange_release
19.2.
2020

We are pleased to announce that the clinical result of ARTEBONE® is positive yielding an outcome similar to patient’s own bone graft

19.2.2020

Type: stock_exchange_release
30.12.
2019

BBS Plc’s liquidity providing (LP) argreement with Mangold Fondkomission AB on the Nasdaq First North Growth Market list in Sweden will expire on 30th December 2019. The management of the company estimates that the LP has not improved the company’s share price formation or liquidity. Only a minority of the company’s shares are listed in Sweden and the share price and trading, despite the LP, have behaved in the same way as the company’s main listing in Finland. The company does not have a LP agreement in Finland.

Type: stock_exchange_release
22.10.
2019

22.10.2019

BBS-Bioactive Bone Substitutes Plc: The patent application regarding a bone protein preparation has been accepted in Canada

Our company BBS-Bioactive Bone Substitutes Plc’s patent application ”A METHOD FOR PREPARING A BONE PROTEIN PREPARATION AND A BONE PROTEIN PREPARATION CONTAINING POLYETHYLENE GLYCOL/GLYCEROL MATRIX AND CALCIUM SALT GRANULES” has been accepted in Canada. The same European and Eurasian patent has been valid about three years.

Type: stock_exchange_release
14.10.
2019

The Board of BBS OYj has today nominated PhD Ilkka Kangasniemi as the CEO of the company, starting 15th of October 2019. Dr. Kangasniemi, who joined the board in the spring 2019, is experienced in commercialization and development of biomaterials and has been in the board and management of several biotech companies.
Short term goals of BBS include transition of the company into a marketing and sales organization.

Type: stock_exchange_release
30.8.
2019

BBS-Bioactive Bone Substitutes Plc (BBS) Interim Report January 1th  – June 30th 2019 (unaudited)

January-June shortly (comparison season 1-6/2018)

Type: stock_exchange_release
30.8.
2019

BBS-Bioactive Bone Substitutes Plc (BBS) Interim Report January 1th  – June 30th 2019 (unaudited)

January-June shortly (comparison season 1-6/2018)

Type: stock_exchange_release
9.7.
2019

Correction to BBS share issue completed 215 new shareholders in Sweden Equity Market Information release, published the 2nd of July 2019 at 9:00 CEST.
The release was published as an Equity Market Information release but should have been released as a Company Announcement. The content of the release is the same as before.

Type: stock_exchange_release
2.7.
2019

BBS – Bioactive Bone Substitutes Oyj (“BBS or “Company”), an innovator in orthobiologics, today announced the final outcome of the share issue to increase the number of shareholders in Sweden (“Offering”), for which the subscription period ended on June 30, 2019. The subscription price of the Offering has been set to SEK 28,10 per share. A total of 114 300 new shares were subscribed in the Offering and the Board of Directors has today decided to approve the subscriptions.

BBS-Bioactive Bone Substitutes

English translation unavailable for BBS-Bioactive Bone Substitutes.
BBS-Bioactive Bone Substitutes